OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ASIR.CM54

Asiri Hospital Holdings PLC

Healthcare Facilities & ServicesVerified

Asiri Hospital Holdings PLC maintains a debt-to-equity ratio of 0.86, indicating a moderate level of leverage, while its current ratio of 0.7 suggests potential liquidity constraints, as current liabilities exceed current assets. The company's liquidity position is assessed as medium risk, with free cash flow of 895,439,100 LKR and operating cash flow of 158,638,340 LKR, but net cash is negative after subtracting total debt. Profitability metrics show a return on equity of 3.09% and a return on assets of 1.26%, both below the typical thresholds for high-performing healthcare firms. These figures suggest that the company is generating modest returns relative to its equity and asset base. The company's revenue is concentrated in its core hospital services, with no disclosed geographic diversification. This lack of diversification may expose the company to regional economic or regulatory risks. Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. Historical revenue of 7,251,395,170 LKR indicates a consistent but moderate performance. Risk factors include a medium liquidity risk and a low dilution risk. The company's capital structure is relatively stable, with no immediate signs of dilution pressure. However, the negative net cash position after subtracting total debt is a concern. Recent events include the latest financial filing, which provides updated financial metrics and confirms the company's ongoing operations. No significant new developments or regulatory changes have been disclosed in the recent transcripts or filings.

30-day price · ASIR.CM+11.40 (+35.6%)
Low$29.80High$47.00Close$43.40As of12 May, 00:00 UTC
Profile
CompanyAsiri Hospital Holdings PLC
TickerASIR.CM
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Asiri Hospital Holdings PLC operates in the healthcare sector, providing hospital services and related healthcare facilities, generating revenue primarily through patient care and medical services.

Classification. Asiri Hospital Holdings PLC is classified under the Healthcare Facilities & Services industry within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Asiri Hospital Holdings PLC maintains a debt-to-equity ratio of 0.86, indicating a moderate level of leverage, while its current ratio of 0.7 suggests potential liquidity constraints, as current liabilities exceed current assets. The company's liquidity position is assessed as medium risk, with free cash flow of 895,439,100 LKR and operating cash flow of 158,638,340 LKR, but net cash is negative after subtracting total debt. Profitability metrics show a return on equity of 3.09% and a return on assets of 1.26%, both below the typical thresholds for high-performing healthcare firms. These figures suggest that the company is generating modest returns relative to its equity and asset base. The company's revenue is concentrated in its core hospital services, with no disclosed geographic diversification. This lack of diversification may expose the company to regional economic or regulatory risks. Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. Historical revenue of 7,251,395,170 LKR indicates a consistent but moderate performance. Risk factors include a medium liquidity risk and a low dilution risk. The company's capital structure is relatively stable, with no immediate signs of dilution pressure. However, the negative net cash position after subtracting total debt is a concern. Recent events include the latest financial filing, which provides updated financial metrics and confirms the company's ongoing operations. No significant new developments or regulatory changes have been disclosed in the recent transcripts or filings.
Key takeaways
  • Asiri Hospital Holdings PLC has a moderate debt-to-equity ratio, indicating a balanced capital structure.
  • The company's return on equity and return on assets are below industry benchmarks, suggesting room for improvement in profitability.
  • The company's liquidity position is medium risk, with a current ratio below 1.
  • Revenue is concentrated in core hospital services, with no geographic diversification disclosed.
  • The company is projected to maintain a stable revenue trajectory with no significant growth or decline expected.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyLKR
Revenue$7.25B
Gross profit$3.29B
Operating income$1.29B
Net income$657.1M
R&D
SG&A
D&A
SBC
Operating cash flow$158.6M
CapEx-$308.2M
Free cash flow$895.4M
Total assets$52.13B
Total liabilities$30.90B
Total equity$21.23B
Cash & equivalents$2.31B
Long-term debt$18.35B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$22.32B$5.80B$3.50B$2.60B
FY-3$24.79B$5.91B$1.47B$636.4M
FY-2$28.57B$3.07B-$215.0M$709.3M
FY-1$31.02B$4.40B$1.64B$1.41B
FY0$35.06B$7.69B$4.87B$5.84B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$39.24B$14.65B$838.7M
FY-3$50.29B$17.72B$1.55B
FY-2$52.55B$21.70B$805.2M
FY-1$54.81B$19.66B$654.1M
FY0$60.71B$24.53B$919.0M
PeriodOCFCapExFCFSBC
FY-4$5.53B-$1.23B$2.60B
FY-3$3.45B-$1.46B$636.4M
FY-2$4.38B-$1.09B$709.3M
FY-1$2.61B-$1.61B$1.41B
FY0$4.68B-$1.40B$5.84B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$7.25B$1.29B$657.1M$895.4M
FQ-6$7.76B$1.39B$416.2M$762.3M
FQ-5$7.77B$1.13B$455.9M-$357.5M
FQ-4$8.24B$590.3M$114.5M$113.9M
FQ-3$8.72B$2.04B$1.16B$1.58B
FQ-2$8.52B$1.69B$1.02B$1.10B
FQ-1$8.86B$1.98B$1.26B$1.41B
FQ0$8.96B$1.98B$1.42B$1.75B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$52.13B$21.23B$2.31B
FQ-6$54.74B$21.06B$1.22B
FQ-5$55.97B$21.52B$743.2M
FQ-4$54.81B$19.66B$654.1M
FQ-3$59.50B$23.94B$920.3M
FQ-2$58.46B$21.92B$791.4M
FQ-1$59.08B$23.29B$815.9M
FQ0$60.71B$24.53B$919.0M
PeriodOCFCapExFCFSBC
FQ-7$158.6M-$308.2M$895.4M
FQ-6$476.2M-$527.8M$762.3M
FQ-5$310.6M-$1.12B-$357.5M
FQ-4$2.61B-$1.61B$113.9M
FQ-3$1.06B-$157.7M$1.58B
FQ-2$1.39B-$670.0M$1.10B
FQ-1$2.81B-$1.11B$1.41B
FQ0$4.68B-$1.40B$1.75B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$21.23B
Net cash-$16.04B
Current ratio0.7
Debt/Equity0.9
ROA1.3%
ROE3.1%
Cash conversion24.0%
CapEx/Revenue-4.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 779 companies
MetricASIR.CMActivity
Op margin17.7%7.7% medp25 -2.4% · p75 15.5%top quartile
Net margin9.1%5.9% medp25 -3.8% · p75 12.8%above median
Gross margin45.3%45.5% medp25 31.1% · p75 62.9%below median
R&D / revenue529.2% medp25 465.2% · p75 593.2%
CapEx / revenue-4.2%-7.0% medp25 -14.9% · p75 -3.2%above median
Debt / equity86.0%25.0% medp25 3.8% · p75 63.3%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 00:14 UTC#080e047c
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 09:50 UTCJob: 7c0e54d8